Purchase Order N6809622P0053

Award Date 9/23/22
Potential Completion Date 10/20/22
Potential Value $85K
Funding Federal Agency
Defense Health Agency
Contracting Federal Agency
Bureau of Medicine and Surgery
Ultimate Awardee
Not listed
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Agana Heights, Guam
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
4
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the Bureau of Medicine and Surgery, a U.S. Navy organization, to Biofire Defense LLC, a for-profit limited liability company. The $88,070.26 contract is for the supply and delivery of respiratory panel kits to the U.S. Naval Hospital in Guam. The contract was awarded on November 23, 2022 and has an ultimate completion date of December 16, 2022. The contract was competed without a set-aside. Biofire Defense LLC has a history of providing...
This firm fixed-price purchase order was awarded by the Defense Health Agency to Biofire Defense LLC, a manufacturer of biological threat identification products, for the delivery of respiratory panel test kits and blood culture kits to the Naval Medical Center San Diego. The award, valued at $872,184.98, has an ultimate completion date of September 20, 2023. Biofire Defense LLC has a history of prior prime and subcontract awards from various federal agencies, including the Department of...
This is a $742,431.36 firm-fixed-price purchase order awarded by the Defense Health Agency to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of Biofire Respiratory Panel 2.1 test kits to the Naval Medical Center San Diego, with a period of performance through March 22, 2023. Biofire Defense has previously received other federal prime and subcontract awards from the Department of Defense,...
This federal contract award to Biofire Defense LLC, a for-profit limited liability company based in Utah, is for the supply of Biofire Film Array reagent kits and equipment maintenance services for the U.S. Naval Hospital in Guam. The $1,588,993.75 firm-fixed-price purchase order was awarded by the Defense Health Agency and has an ultimate completion date of February 9, 2030. The contract includes a base year and four one-year option periods. The original solicitation, RFQ HT941025Q2014,...
This firm fixed price purchase order was awarded by the Defense Health Agency to Biofire Defense LLC for $365,226. The contract calls for the delivery of 90 Biofire Respiratory Panel 2.1 in vitro diagnostic test kits to aid the Department of Defense's response to the COVID-19 pandemic. Per the terms, Biofire will ship 45 kits on May 18, 2022 and the remaining 45 kits on September 14, 2022 to the Naval Medical Center in San Diego. The original solicitation sought quotes for the 90 Biofire RP2.1...
The Defense Health Agency (DOD) awarded a $746,778 firm fixed price purchase order contract to Biofire Defense LLC of Salt Lake City, Utah. The contract is for the delivery of 184 kits containing 30 tests each of Biofire Defense's RESPIRATORY PANEL 2.1 in vitro diagnostic test panels. The place of performance is Biofire Defense's facility in Salt Lake City and the period of performance runs from June 16, 2022 through September 14, 2022. The contract was awarded under the National Interest Action...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency (DHA) to Biofire Defense LLC, a manufacturer of biological agent identification products. The contract is for the delivery of MOLECULAR DIAGNOSTICS KITS and has a ceiling value of $3,498,082.42 with a period of performance through September 29, 2029. There is no set-aside designation for this contract. Biofire Defense LLC has previously been awarded other prime and subcontract work with the Department of...
This is a $90,878.59 firm fixed price delivery order awarded by the U.S. Navy's Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The award is for the delivery of Film Array kits, including the GI Panel, Bio Threat E, and FAIV Kits, which support respiratory infection testing. The contract has no set-aside designation and was issued under the Multiple Award Schedule (MAS) contract vehicle....
This is a $227,968 firm fixed price purchase order contract awarded by the Department of the Navy Bureau of Medicine and Surgery to Biofire Defense LLC, a for-profit limited liability company that manufactures biological agent identification products. The contract is for the delivery of Global Fever Panel Kits, with a completion date of October 30, 2020. The contract has no set-aside designation. Biofire Defense has previously received other federal contracts and grants related to biological...
This is a $114,761.00 firm fixed-price purchase order awarded by the Department of the Navy Bureau of Medicine and Surgery to Biofire Defense LLC, a limited liability company and manufacturer of goods, for the delivery of a FILMARRAY RESP PANEL product under PRODUCT CODE 423742. The contract has a completion date of September 30, 2022 and was awarded on July 12, 2022. There is no set-aside designation noted. Biofire Defense is an experienced federal contractor, having previously provided...

This $84,649.21 firm fixed price purchase order was awarded by the Defense Health Agency (DHA) to Biofire Defense LLC, a biodefense and infectious disease diagnostics company, on September 23, 2022. The contract is for the delivery of RP2.1 DE NOVO PANEL KIT 30 TEST products to the U.S. Naval Hospital in Guam, with a completion date of October 20, 2022. This award is not associated with a set-aside program. Biofire Defense has previously received other prime and subcontract awards from DoD agencies, the Department of State, National Institutes of Health, and the Department of Health and Human Services for a range of biological threat detection, infectious disease testing, and public health preparedness products and services. This includes a $6.2 million cooperative agreement from the DoD's Washington Headquarters Service to expand manufacturing capacity for DoD COVID test kits.

Generated 4/1/25, 5:42 PM